Cheng-Kai Hsu

582 total citations
27 papers, 385 citations indexed

About

Cheng-Kai Hsu is a scholar working on Nephrology, Infectious Diseases and Health, Toxicology and Mutagenesis. According to data from OpenAlex, Cheng-Kai Hsu has authored 27 papers receiving a total of 385 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Nephrology, 5 papers in Infectious Diseases and 5 papers in Health, Toxicology and Mutagenesis. Recurrent topics in Cheng-Kai Hsu's work include Dialysis and Renal Disease Management (7 papers), Acute Kidney Injury Research (5 papers) and Effects and risks of endocrine disrupting chemicals (3 papers). Cheng-Kai Hsu is often cited by papers focused on Dialysis and Renal Disease Management (7 papers), Acute Kidney Injury Research (5 papers) and Effects and risks of endocrine disrupting chemicals (3 papers). Cheng-Kai Hsu collaborates with scholars based in Taiwan, United States and Japan. Cheng-Kai Hsu's co-authors include I‐Wen Wu, Yih-Ting Chen, Yung‐Chang Chen, Shih‐Chieh Shao, Ming‐Jui Hung, Chun‐Yu Chen, Heng-Jung Hsu, Chin‐Chan Lee, Chiao‐Yin Sun and Heng‐Chih Pan and has published in prestigious journals such as PLoS ONE, Scientific Reports and Nutrients.

In The Last Decade

Cheng-Kai Hsu

25 papers receiving 374 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cheng-Kai Hsu Taiwan 11 173 116 55 54 45 27 385
Yih-Ting Chen Taiwan 11 138 0.8× 170 1.5× 71 1.3× 63 1.2× 38 0.8× 25 411
Renhua Sun China 10 86 0.5× 130 1.1× 47 0.9× 75 1.4× 33 0.7× 17 335
Uttam Reddy United States 11 149 0.9× 101 0.9× 56 1.0× 105 1.9× 21 0.5× 36 530
Paul Gabarre France 6 105 0.6× 302 2.6× 105 1.9× 117 2.2× 49 1.1× 26 484
CB Leung Hong Kong 5 86 0.5× 214 1.8× 155 2.8× 36 0.7× 20 0.4× 10 402
Gaetano Piccinocchi Italy 12 60 0.3× 52 0.4× 28 0.5× 48 0.9× 12 0.3× 32 359
Katherine L. Hull United Kingdom 10 232 1.3× 71 0.6× 11 0.2× 106 2.0× 28 0.6× 27 501
Murilo Guedes Brazil 13 195 1.1× 48 0.4× 14 0.3× 70 1.3× 18 0.4× 49 423
Başol Canbakan Türkiye 12 184 1.1× 48 0.4× 15 0.3× 152 2.8× 50 1.1× 35 524
Nicole Ali United States 12 180 1.0× 66 0.6× 33 0.6× 153 2.8× 60 1.3× 39 559

Countries citing papers authored by Cheng-Kai Hsu

Since Specialization
Citations

This map shows the geographic impact of Cheng-Kai Hsu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheng-Kai Hsu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheng-Kai Hsu more than expected).

Fields of papers citing papers by Cheng-Kai Hsu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cheng-Kai Hsu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheng-Kai Hsu. The network helps show where Cheng-Kai Hsu may publish in the future.

Co-authorship network of co-authors of Cheng-Kai Hsu

This figure shows the co-authorship network connecting the top 25 collaborators of Cheng-Kai Hsu. A scholar is included among the top collaborators of Cheng-Kai Hsu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cheng-Kai Hsu. Cheng-Kai Hsu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hsu, Cheng-Kai, Lun‐Ching Chang, Yih-Ting Chen, et al.. (2025). Effects of Sodium-Glucose Cotransporter-2 Inhibitors on Modulating Protein-Bound Uremic Toxins and Gut Microbiota in Predialysis CKD Patients. Kidney360. 6(9). 1472–1481. 1 indexed citations
2.
Hsu, Heng-Jung, Heng‐Chih Pan, Chiao‐Yin Sun, et al.. (2025). Community-based insights into the connection between endocrine-disrupting chemicals and depressive symptoms. Current Research in Toxicology. 8. 100225–100225. 1 indexed citations
4.
Chen, Chun‐Yu, Chin‐Chan Lee, Chiao‐Yin Sun, et al.. (2025). Perfluoroalkyl substances exposure and kidney function decline in a community-based prospective cohort. Ecotoxicology and Environmental Safety. 303. 119015–119015. 1 indexed citations
5.
Wei, Yi‐Chia, Chiao‐Yin Sun, Heng-Jung Hsu, et al.. (2024). Endocrine-Disrupting Chemicals Exposure and Neurocognitive Function in the General Population: A Community-Based Study. Toxics. 12(7). 514–514. 2 indexed citations
6.
Lee, Chin‐Chan, Chun-Yu Chen, I‐Wen Wu, et al.. (2024). Effect of Electronic Moxibustion in Patients with IDH: A Randomized Crossover Pilot Study. International Journal of General Medicine. Volume 17. 5793–5805.
7.
Chen, Chun‐Yu, Chin‐Chan Lee, Heng-Jung Hsu, et al.. (2024). Long-term impacts of endocrine-disrupting chemicals exposure on kidney function: A community-based cohort study. Environmental Toxicology and Pharmacology. 106. 104379–104379. 14 indexed citations
8.
Lee, Chin‐Chan, Chia‐Chun Chen, Cheng-Kai Hsu, et al.. (2023). Urinary microRNA in Diabetic Kidney Disease: A Literature Review. Medicina. 59(2). 354–354. 8 indexed citations
9.
10.
Wu, I‐Wen, Huang‐Yu Yang, Cheng-Kai Hsu, et al.. (2022). Deep immune profiling of patients with renal impairment unveils distinct immunotypes associated with disease severity. Clinical Kidney Journal. 16(1). 78–89. 10 indexed citations
11.
Hsu, Cheng-Kai, Tai‐Shuan Lai, Yih-Ting Chen, et al.. (2021). Renal function trajectories in hepatitis C infection: differences between renal healthy and chronic kidney disease individuals. Scientific Reports. 11(1). 17197–17197. 5 indexed citations
12.
Hsu, Cheng-Kai, Shih‐Chi Su, Lun‐Ching Chang, et al.. (2021). Effects of Low Protein Diet on Modulating Gut Microbiota in Patients with Chronic Kidney Disease: A Systematic Review and Meta-analysis of International Studies. International Journal of Medical Sciences. 18(16). 3839–3850. 24 indexed citations
13.
Hsu, Cheng-Kai, I‐Wen Wu, Yih-Ting Chen, et al.. (2020). Value of the high-sensitivity troponin T assay for diagnosis of acute myocardial infarction in patients with and without renal insufficiency. Renal Failure. 42(1). 1142–1151. 4 indexed citations
14.
Chen, Yih-Ting, Shih‐Chieh Shao, Cheng-Kai Hsu, et al.. (2020). Incidence of acute kidney injury in COVID-19 infection: a systematic review and meta-analysis. Critical Care. 24(1). 346–346. 113 indexed citations
15.
Chen, Yih-Ting, Chang‐Chyi Jenq, Cheng-Kai Hsu, et al.. (2020). Acute kidney disease and acute kidney injury biomarkers in coronary care unit patients. BMC Nephrology. 21(1). 207–207. 30 indexed citations
16.
Hsu, Cheng-Kai, I‐Wen Wu, Yih-Ting Chen, et al.. (2020). Acute kidney disease stage predicts outcome of patients on extracorporeal membrane oxygenation support. PLoS ONE. 15(4). e0231505–e0231505. 19 indexed citations
17.
Lin, Ching‐Kai, Chien-Hsun Wu, Sui‐Yuan Chang, et al.. (2020). Cardiac function evaluation of bone marrow mesenchymal stromal cells intracoronary transplantation in acute myocardial infarction Lee-Sung mini-PIG model. Cytotherapy. 22(5). S75–S75. 1 indexed citations
18.
Hsu, Cheng-Kai, et al.. (2020). International Real Estate Review. International Real Estate Review. 23(3). 417–432. 1 indexed citations
19.
Chen, Yih-Ting, Heng-Jung Hsu, Cheng-Kai Hsu, et al.. (2019). Correlation between spot and 24h proteinuria: Derivation and validation of equation to estimate daily proteinuria. PLoS ONE. 14(4). e0214614–e0214614. 15 indexed citations
20.
Hsu, Cheng-Kai, Chin‐Chan Lee, Yih-Ting Chen, et al.. (2018). Multidisciplinary predialysis education reduces incidence of peritonitis and subsequent death in peritoneal dialysis patients: 5-year cohort study. PLoS ONE. 13(8). e0202781–e0202781. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026